EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.1.3.74 | Autoimmune Diseases |
15452547 |
Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 1 3 |
3.1.3.74 | Carcinoma, Hepatocellular |
3007703 |
Azo dye-induced alterations in vitamin B-6 metabolism and in pyridoxal 5'-phosphate-binding proteins in rat liver. |
diagnostic usage unassigned |
2 0 |
3.1.3.74 | Epilepsy |
31320629 |
PLPP/CIN-mediated NEDD4-2 S448 dephosphorylation regulates neuronal excitability via GluA1 ubiquitination. |
causal interaction therapeutic application unassigned |
3 4 0 |
3.1.3.74 | Epilepsy |
32561413 |
PLPP/CIN-mediated Mdm2 dephosphorylation increases seizure susceptibility via abrogating PSD95 ubiquitination. |
causal interaction ongoing research therapeutic application unassigned |
4 2 4 0 |
3.1.3.74 | Lung Neoplasms |
15452547 |
Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 1 3 |
3.1.3.74 | Neoplasms |
6259164 |
Vitamin B6 metabolism in Morris hepatomas. |
causal interaction diagnostic usage unassigned |
4 3 0 |
3.1.3.74 | Neoplasms |
15452547 |
Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 1 3 |
3.1.3.74 | Neoplasms |
26549022 |
Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness. |
ongoing research unassigned |
1 0 |
3.1.3.74 | Nervous System Diseases |
15452547 |
Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 1 3 |
3.1.3.74 | Seizures |
28993724 |
PLPP/CIN Regulates Seizure Activity by the Differential Modulation of Calsenilin Binding to GluN1 and Kv4.2 in Mice. |
ongoing research unassigned |
2 0 |